HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S./EU harmonization

This article was originally published in The Rose Sheet

Executive Summary

Cooperation between the Interagency Coordinating Committee on the Validation of Alternative Methods and the European Centre for the Validation of Alternative Methods for developing animal alternative tests for cosmetics "needs further strengthening through bilateral contacts with the aim of mutual acceptance of alternative methods," U.S. and European Commission regulatory authorities maintain during a June 20 summit in Washington, D.C. Recommendation is presented as part of the 2005 Roadmap for U.S.-EU Regulatory Cooperation, which also states FDA and EU Directorates General for Enterprise and Industry should collaborate on issues like cosmetics labeling, standardized labeling for sunscreens and the "regulation of hair dyes in the framework of bilateral meetings" and through the multilateral Cosmetics Harmonization and International Cooperation process...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013161

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel